Active10976444Private limited companyNew Eltham

FINE PHARM LIMITED

Significant control: Iraj Rahavi Ezabadi (significant control)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Coming soon · product and service lists

What does Fine Pharm Limited sell?

Registered activity: Other human health activities (SIC 86900). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

FINE PHARM LIMITED is an active private limited company (company number 10976444) incorporated on 22 September 2017, registered in New Eltham. Its registered activity is other human health activities (SIC 86900). Latest small accounts cover the period ending 30 September 2025, showing net assets of £1,055 and cash of £7,067, with 2 employees on average. Net assets rose 137% on the prior period (−£2,886).

Peer position · net assets

By net assets it sits in the lower half of 8,029 comparable companies in London (median £1,318, upper quartile £16k).

02

Ownership and control

1 active
  • Mr Iraj Rahavi Ezabadi
    Individual · since 22 September 2017
    • has significant influence or control

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
22 September 20179 yrs ago
Next accounts due
30 June 2027in 249 days
Confirmation statement due
6 October 2027in 347 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 86900
Other human health activities
Accounts type
Total Exemption Full
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 30 September 2025
Net assets
£1,055
vs Sept 2024
Cash at bank
£7,067
−9%vs Sept 2024
Turnover
Not reported
Employees
2
No changevs Sept 2024
Net assets
£1,055
Cash at bank
£7,067
Average employees
2
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
30 September 2025£1,055£7,067£7,796———2
30 September 2024−£2,886£7,793£0———2
Cash per employee£3,534Cash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £1,055 at 30 September 2025
  • Net assets up 10% or more on the prior period+136.6% vs prior period
  • Incorporated five or more years agoIncorporated 22 September 2017

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 347 days
  2. Next accounts duein 249 days
  3. Accounts period endNet assets £1,055 · small accounts
  4. Accounts period endNet liabilities £2,886 · small accounts
  5. Incorporated
08

Similar companies in London

Same activity (other human health activities), closest in incorporation date
09

Reminders for FINE PHARM LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.